Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pedometers for Gestational Diabetes (PEG)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recruitment status was:  Active, not recruiting
University of Michigan
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Identifier:
First received: March 16, 2009
Last updated: September 9, 2010
Last verified: September 2010
Ten to 50% of women with gestational diabetes (GDM), or glucose intolerance first recognized during pregnancy, develop diabetes within 5 years after delivery. Although intensive interventions can reduce diabetes incidence in women with impaired glucose tolerance, it is unknown if such strategies would be effective in women with GDM. Women with recent GDM, even though no longer pregnant, face significant barriers to lifestyle modification, including caregiving responsibilities and low perception of risk. Web-based programs can reinforce physical activity through visual feedback of pedometer output, tailored messaging, education, and on-line communities. Such a program is currently available for adults with chronic disease and is led by Dr. Richardson, a co-PI on this application. Using data from focus group and survey work conducted by Dr. Kim, the other co-PI, this program can be modified to women with recent GDM. For Specific Aim 1, we propose to adapt a chronic disease web-based pedometer program to women with recent GDM. For Specific Aim 2, we propose to conduct a pilot and feasibility study of the program. The intervention will last 12 weeks.

Condition Intervention
Gestational Diabetes
Behavioral: Stepping Up to Health

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Type 2 Diabetes Risk in Women With Gestational Diabetes

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • Weight loss [ Time Frame: Pre-post ]
  • Glucose tolerance [ Time Frame: Pre-Post ]

Secondary Outcome Measures:
  • Hemoglobin A1c [ Time Frame: Pre-post ]
  • Step counts [ Time Frame: Pre-Post ]
  • Insulin [ Time Frame: Pre-post ]

Estimated Enrollment: 60
Study Start Date: July 2009
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Stepping Up to Health
Behavioral: Stepping Up to Health
Internet-mediated pedometer-based intervention with gradually increasing goals and feedback on step counts. Also includes educational content targeted at women who have had gestational diabetes about exercise, diet & nutrition and prevention.
No Intervention: 2
Usual care group


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Gestational diabetes diagnosis within past three years
  • Access to computer with internet, USB port and Windows XP or Vista
  • Regular email user (weekly or more)
  • Can walk a block on her own
  • Sedentary (less than 150 minutes purposeful physical activity per week)

Exclusion Criteria:

  • Pregnancy
  • Unable to consent legally
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00862602

United States, Michigan
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Michigan
Principal Investigator: Catherine Kim, MD, MPH University of Michigan
  More Information

Responsible Party: Catherine Kim, MD, MPH, University of Michigan Health System Identifier: NCT00862602     History of Changes
Other Study ID Numbers: K23DK071552 ( US NIH Grant/Contract Award Number )
R03DK083332 ( US NIH Grant/Contract Award Number )
Study First Received: March 16, 2009
Last Updated: September 9, 2010

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
gestational diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications processed this record on April 24, 2017